Authors: SARKIS AS BAJORIN DF REUTER VE HERR HW NETTO G ZHANG ZF SCHULTZ PK CORDONCARDO C SCHER HI

Citation: As. Sarkis et al., PROGNOSTIC VALUE OF P53 NUCLEAR OVEREXPRESSION IN PATIENTS WITH INVASIVE BLADDER-CANCER TREATED WITH NEOADJUVANT MVAC, Journal of clinical oncology, 13(6), 1995, pp. 1384-1390

Authors: SCHULTZ PK HERR HW ZHANG ZF BAJORIN DF SEIDMAN A SARKIS A FAIR WR SCHERR D BOSL GJ SCHER HI

Citation: Pk. Schultz et al., NEOADJUVANT CHEMOTHERAPY FOR INVASIVE BLADDER-CANCER - PROGNOSTIC FACTORS FOR SURVIVAL OF PATIENTS TREATED WITH M-VAC WITH 5-YEAR FOLLOW-UP, Journal of clinical oncology, 12(7), 1994, pp. 1394-1401

Authors: WARD SL ALLEN TT CHAVERS RD ROBERTSON TN SCHULTZ PK

Citation: Sl. Ward et al., DIAGNOSING PRODUCTION PROBLEMS WITH DOWNHOLE VIDEO SURVEYING AT PRUDHOE BAY, Journal of petroleum technology, 46(11), 1994, pp. 973-978

Authors: SCHULTZ PK KELLY WK BEGG C LIEBERTZ C COHEN L SCHER HI

Citation: Pk. Schultz et al., POST-THERAPY CHANGE IN PROSTATE-SPECIFIC ANTIGEN LEVELS AS A CLINICAL-TRIAL END-POINT IN HORMONE-REFRACTORY PROSTATIC-CANCER - A TRIAL WITH10-ETHYL-DEAZA-AMINOPTERIN, Urology, 44(2), 1994, pp. 237-242